Discrimination of N2a and N2b by EBUS-TBNA: is a Change of the Needle Necessary?
ConditionLung Cancer (Diagnosis)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Vienna
About this trial
During EBUS staging in patients with mediastinal lymphadenopathy, it is planned to perform a first round of staging with change of the needle between all lymph nodes and a second round of staging without change of the needle.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Pulmonary lesion suspicious for lung cancer or histologically confirmed lung cancer
indication for mediastinal staging
Disqualifiers
None
Trial design
Design model
Single group
Treatments tested in this trial
EBUS-TBNA
Diagnostic testDuring EBUS staging, the needle well be changed between all lymph node stations in a first round. The EBUS staging will be repeated without the change of the needle between the lymph node stations.
Treatment groups
30 Participants
are divided into 1 treatment groupGroup A: STudy groupExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Agreement between the two rounds of EBUS staging
Time frame
18 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov